Skip to main content
NCBI home page
Iranian Journal of Arthropod-Borne Diseases logoLink to Iranian Journal of Arthropod-Borne Diseases
. 2011 Dec 31;5(2):69–76.

Production and Purification of Anti-Rhombomys opimus Immunoglobulins

AA Akhavan 1,#, R Ghods 2,#, M Jeddi-Tehrani 3, MR Yaghoobi-Ershadi 1, A Khamesipour 4, AR Mahmoudi 2,*
PMCID: PMC3385573  PMID: 22808420

Abstract

Background:

Zoonotic cutaneous leishmaniasis (ZCL) is an increasing public health problem in some endemic regions. Horseradish peroxidase (HRP) conjugated rabbit anti-Rhombomys opimus (R. opimus) Ig is needed for immunoblotting and ELISA tests used to explore the immune response of the rodents against the sand fly saliva. In this study, the production of HRP conjugated rabbit anti-R. opimus Ig was conducted for the first time.

Methods:

Rhombomys opimus Ig was purified from serum by protein G affinity chromatography column and injected into rabbit to produce anti-R. opimus Ig antibody. The titration of antibody against R. opimus Ig in rabbit serum was checked using indirect ELISA. Rabbit anti-R. opimus Ig was purified by Sepharose-4B-R. opimus Ig column. Reactivity of this antibody was assessed by indirect ELISA and was conjugated to HRP by periodate method.

Results:

Approximately 3.5 mg Ig was purified from 1 ml R. opimus serum using protein G affinity chromatography column. The molecular weight of purified R. opimus Ig was estimated about 150 kDa by SDS-PAGE. Nearly 2.3 mg rabbit anti-R. opimus Ig was purified from 1 ml immunized rabbit serum. The purified antibody was conjugated to HRP and the optimum titer of HRP conjugated rabbit anti-R. opimus Ig was determined as 1:8000 using direct ELISA.

Conclusion:

HRP conjugated rabbit anti-Gerbil IgG has been produced by a few companies, but to our knowledge HRP conjugated rabbit anti-R. opimus Ig is not commercially available. Production of HRP conjugated rabbit anti-R. opimus Ig is considerably helpful for immunological studies of R. opimus, the main reservoir host of ZCL in Iran as well as some other countries.

Keywords: Rhombomys opimus, Polyclonal antibody, Zoonotic cutaneous leishmaniasis, Immunoglobulin, Iran

Introduction

Zoonotic cutaneous leishmaniasis (ZCL) is still a public health problem in some of the regions of the endemic areas. Leishmania major, the causative agent of the ZCL of the old world, is widely distributed in different populations of rodents in arid and savannah areas. The disease is transmitted to rodents and other vertebrate hosts by phelebotominae sand flies (Gramiccia and Gradoni 2005). Rodents of the subfamily of Gerbillinae are the main reservoirs of ZCL in Iran and other countries where the disease is endemic (Dubrovsky 1979, Strelkoova 1996, Yaghoobi-Ershadi et al. 1996). Rhombomys opimus (Cricetidae: Gerbillinae) is the main reservoir host of the agent over the vast areas of the Turan lowland (west and south Kazakhstan and central Asia with adjacent parts of Afghanistan and Iran), Mongolia, and seemingly, in some provinces of China. Naturally infected R. opimus were found in more than 200 places of Turan lowland. This gerbil is also found to be naturally infected with L. turanica and L. gerbilli (Strelkova 1996, Akhavan et al. 2010a, 2010b, 2010c). Well-described stable ZCL system in central Asia, Afghanistan and Iran (central and north-east) are associated with R. opimus, the main reservoir, and Phlebotomus papatasi, the main vector (Javadian 1988, Yaghoobi-Ershadi and Javadian 1996, Javadian et al. 1998, Yaghoobi-Ershadi et al. 1996, 2003, Gramiccia and Gradoni 2005, Yaghoobi-Ershadi 2008).

Investigation on immunogenic components of sand fly saliva and the immune response of the host against it, also interaction among the parasite, sand fly and host is necessary to find possible tools to control the disease specially producing anti Leishmania vaccine and/or transmission blocking vaccine (Akhavan 2011). Detecting the immune response of the host to saliva of sand flies can also be used as a marker of transmission risk of the disease (Barral et al. 2000). Study on the immune response of R. opimus, the main reservoir host of ZCL in central and northeast of Iran, to infection of L. major, the causative agent of the disease, seems to be necessary. Horseradish peroxidase (HRP) conjugated rabbit anti-R. opimus Ig is needed for immunoblotting and ELISA tests, used to find the immune response of the rodents against the sand fly saliva.

As this material is not produced commercially in the world, its production was essential and inescapable. To our knowledge, in the present study production of HRP conjugated rabbit anti-R. opimus Ig has been produced for the first time.

Materials and Methods

Rhombomys opimus serum collection

To purify R. opimus Ig, sera were obtained from wild great gerbils collected from natural habitat in Sejzi rural district, Esfahan Province, central Iran. Great gerbils were anaesthetized (ketamin hydrochloride 60 mg/kg and xylazine 5 mg/kg, intramuscularly) and then the blood sample was collected. The individual sera was isolated and kept at −20 °C until use.

Purification of R. opimus Ig and polyclonal rabbit anti-R. opimus Ig

Rhombomys opimus Ig was purified using HiTrap protein G HP affinity chromatography column (GE Healthcare, Uppsala, Sweden). The 1:5 diluted serum in PBS (0.15M, pH= 7.2) was centrifuged, filtered by 0.2 μm filter and passed through the HiTrap protein G HP affinity chromatography column. Then the column was washed with PBS. The attached R. opimus Ig to the column was isolated from the column using Gly-HCl (0.2 M, pH= 2.5). Isolated Ig was dialyzed against PBS and finally the purified R. opimus Ig was stored at −20 °C.

For purification of rabbit anti-R. opimus Ig from rabbit serum, a Sepharose-4B-R. opimus Ig affinity chromatography column was prepared according to the Amersham Biosciences company instructions (71-7086-00 Edition AC). Using this column, the rabbit anti-R. opimus Ig was purified from rabbit serum as described for R. opimus Ig purification (see above).

Concentration of purified R. opimus Ig and rabbit anti-R. opimus Ig was determined by reading the optical density (OD) of samples at 280 nm and calculation of the concentrations regarding to extinction coefficient of IgG molecule.

Purity assessment of purified R. opimus Ig

Molecular weight and purity of the R. opimus Ig were determined using SDS-PAGE in non-reducing conditions, 8% separating gel and 4% stacking gel (according to Bio-Rad guideline).

Immunization of New Zealand white rabbit with R. opimus Ig

A female New Zealand white rabbit aged 6–7 months was immunized with R. opimus Ig using Hudson and Hay’s method (Hudson and Hay 1991) with minor modifications. Rabbit was injected intramuscularly into the thigh muscle with 250 μg R. opimus Ig mixed with Complete Freund’s Adjuvant, and 4 booster injections of 125 μg of R. opimus Ig mixed with Incomplete Freund's Adjuvant at 4 weeks intervals between the first and second injection and 2 weeks intervals between subsequent injections.

Before each immunization, blood sample was taken from the marginal vein of the rabbit ear, centrifuged and the sera were checked for anti-R. opimus Ig antibody using ELISA method.

Animal care and the procedures were conducted according to the guidelines of the animal care and Ethics Committee of Avicenna Research Institute.

Antiserum titration and reactivity assessment of purified polyclonal rabbit anti-R. opimus Ig by ELISA

Rabbit anti-R. opimus Ig titer was evaluated using ELISA. Briefly, 10 μg/ml of purified R. opimus Ig in 100 μl was added to each well of microtiter polystyrene strips (Maxisorp, Nunc, Roskilde, Denmark) and incubated at 37° C for 1.5 hours, 2 wells received only PBS as negative control, then the plate was washed 3 times with PBS-Tween (0.05%) (PBS-T), the wells were then blocked using 3% skim milk for 1.5 hours at 37° C. The plate was washed 3 times and serial dilutions of rabbit anti-R. opimus Ig serum from 1:1000 to 1:64000 dilutions were added and incubated for 1.5 hours at 37° C. Two other wells received PBS as primary antibody step negative control. After three times washing, HRP conjugated sheep anti-rabbit Ig (Avicenna Research Institute, Tehran, Iran) was added as secondary antibody and incubated for 1.5 hours at 37 °C. After the last wash, the reaction was visualized using TMB substrate (USB, Cleveland, USA) and the optical density measured by ELISA reader (Anthos 2020, Cambridge, England) at 450 nm.

Reactivity of purified polyclonal rabbit anti-R. opimus Ig with related antigen was assessed by indirect ELISA test. ELISA procedures including coating antigen and secondary antibody were performed as described above. However, the serial dilutions of purified rabbit anti-R. opimus Ig (by two fold dilutions from 10000 to 1.2 ng/ml) were added as primary antibody.

Conjugation of polyclonal rabbit anti-R. opimus Ig with HRP

Conjugation of polyclonal rabbit anti-R. opimus Ig with HRP was performed by periodate method (Wilson and Nakane 1978). Briefly, HRP was oxidized by sodium periodate. Oxidized HRP was mixed by rabbit anti-R. opimus Ig. Then, sodium borohydride was added to this mixture and finally the conjugate was purified from excess reagents by dialysis.

Titration of HRP conjugated rabbit anti-R. opimus Ig by ELISA

The optimum titer of HRP conjugated rabbit anti-R. opimus Ig was assessed by direct ELISA according to the procedure described for the antiserum titration ELISA. The wells were coated by R. opimus Ig (10 μg/ml) as coating antigen and two wells were coated with PBS only as negative control. Titration of HRP conjugated rabbit anti-R. opimus Ig was performed by two fold dilutions from 1:250 to 1:128000.

Results

From 1 ml R. opimus serum 3.5 mg R. opimus Ig was purified. The purified R. opimus Ig related SDS-PAGE shows high purity of the purified Ig. Regarding to the molecular weight of mouse IgG as a molecular weight marker, the molecular weight of purified R. opimus Ig is about 150 kDa (Fig. 1).

Fig. 1.

Fig. 1.

Open in a new tab

The SDS-PAGE analysis of purified R. opimus Ig by HiTrap Protein G HP affinity chromatography column

The results showed that the specific antibodies were detectable following the first injection in rabbit. After the second injection, the antibody titer reached near the maximum level and there was no remarkable increase following subsequent injections. However, booster injections resulted in gradual and stepwise increase in the specific antibody titer against R. opimus Ig (Fig. 2).

Fig. 2.

Fig. 2.

Open in a new tab

Titration curve of rabbit anti-R. opimus Ig by indirect ELISA

From 5 ml immunized rabbit serum 11.5 mg rabbit anti-R. opimus Ig was purified. It means that there was 2.3 mg rabbit anti-R. opimus Ig in each ml of the immunized rabbit serum.

The results showed strong reactivity of this antibody with related antigen and this antibody can detect its antigen in very low concentrations of about 1.2 ng/ml (Fig. 3).

Fig. 3.

Fig. 3.

Open in a new tab

Reactivity test of purified rabbit anti-R. opimus Ig by indirect ELISA

After the HRP conjugation, it was necessary to find the optimum dilution of HRP conjugated rabbit anti-R. opimus Ig by direct ELISA. Optimum dilution for a specific conjugate is the highest dilution of conjugate which can produces the highest signal.

According to the HRP conjugated rabbit anti-R. opimus Ig titration curve, the optimum dilution of this conjugate is 1:8000 and it shows that the efficiency of conjugation is high (Fig. 4).

Fig. 4.

Fig. 4.

Open in a new tab

Titration of HRP conjugated rabbit anti-R. opimus Ig by direct ELISA

Discussion

HRP conjugated rabbit anti-Gerbil IgG is produced by a few companies; however, to our knowledge there is no record of production of HRP conjugated rabbit anti-R. opimus Ig. Production of HRP Conjugated Rabbit anti-R. opimus Ig is needed for serological and immunological studies of R. opimus, the main reservoir host of ZCL in Iran as well as some other countries, which may lead to plan immunological control of the disease (Akhavan 2011).

Phlebotomus papatasi, vector of ZCL, co-injects Leishmania parasites along with saliva into the skin of R. opimus while feeding. Saliva from the sand fly is known to have pharmacological as well as immunomodulatory activities such as vasodilatory and anticlotting effects which exacerbate the infectivity of the parasite (Kamhawi 2000). Investigation on the immune response of the host against salivary gland antigens of the vector, also interaction among the parasite, sand fly and host are necessary to find possible tools to control the disease, especially in developing anti Leishmania vaccine and/or transmission blocking vaccine. Detecting the immune response of the host to saliva of the sand fly may also be used as a marker of transmission risk of the disease (Barral et al. 2000). The HRP conjugated rabbit anti-R. opimus Ig produced in this study helps the investigators to study on the immune response of R. opimus, to L. major exposure and infection. The HRP conjugated antibody is needed for immunoblotting and ELISA tests, which are used to detect the immune response of the rodents against the sand fly saliva.

Purification of R. opimus Ig is a necessary step for production of polyclonal antibody. No established protocol was recorded for purification of R. opimus Ig. In this regard, considering the fact that R. opimus is a mammal belonging to the order Rodentia and according to previous studies (Kemp 2005), protein G could adsorb Ig molecules from many mammals and rodents such as human, mouse and rabbit. Thus it seems reasonable that protein G is a suitable candidate for purification of IgG molecules from R. opimus serum. Using this method, 3.5 mg R. opimus Ig was obtained from 1 ml serum.

Moreover, due to the lack of knowledge about the molecular size of R. opimus Ig, another rodent IgG (mouse) was used as a standard for molecular weight determination in SDS-PAGE. The very similar migration of R. opimus Ig in the polyacrylamide gel to that of murine IgG allowed us to estimate it as around 150 kDa.

A high titer of rabbit anti-R. opimus Ig production after the first injection of R. opimus Ig showed that R. opimus Ig mixed with adjuvant was immunogenic in rabbit, so that after the second injection, the antiserum titer in the rabbit hardly increased. However, we continued the immunizations to increase the avidity or affinity of the produced antibodies.

In conclusion, this study describes the successful purification of R. opimus Ig and production of polyclonal antibodies against it in rabbit.

Acknowledgments

The authors are grateful to Ms L Balaie Goli, Ms M Babaei, Ms M Darzi, Mr J Mahmoudian, Ms L Eini and Mr A Moradzadeh, Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR and Mr Arandian, Ms Shareghi, Mr Jafari and Mr Abdoli, Isfahan Health Research Center, National Institute of Health Research, TUMS for their kind collaboration. This research was financially supported by a grant of Avicenna Research Institute (ARI), Project No.1689-33. The authors declare that they have no conflicts of interest.

References

  1. Akhavan AA, Mirhendi H, Khamesipour A, Alimohammadian MH, Rassi Y, Bates P, Kamhawi S, Valenzuela JG, Arandian MH, Abdoli H, Jalali-Zand N, Jafari R, Shareghi N, Ghanei M, Yaghoobi-Ershadi MR. Leishmania species: Detection and identification by nested PCR assay from skin samples of rodent reservoirs. Exp Parasitol. 2010a;126:552–556. doi: 10.1016/j.exppara.2010.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Akhavan AA, Yaghoobi-Ershadi MR, Khamesipour A, Mirhendi H, Alimohammadian MH, Rassi Y, Arandian MH, Jafari R, Abdoli H, Shareghi N, Ghanei M, Jalali-zand N. Dynamics of Leishmania infection rates in Rhombomys opimus (Rodentia: Gerbillinae) population of an endemic focus of zoonotic cutaneous leishmaniasis in Iran. Bull Soc Pathol Exot. 2010b;103(2):84–89. doi: 10.1007/s13149-010-0044-1. [DOI] [PubMed] [Google Scholar]
  3. Akhavan AA, Yaghoobi-Ershadi MR, Mirhendi H, Alimohammadian MH, Rassi Y, Shareghi N, Jafari R, Arandian MH, Abdoli H, Ghanei M, Jalali-zand N, Khamesipour A. Molecular epizootiology of rodent leishmaniasis in a hyperendemic area of Iran. Iran J Public Health. 2010c;39(1):1–7. [PMC free article] [PubMed] [Google Scholar]
  4. Akhavan AA. Immune Response of Great Gerbil against Phlebotomus papatasi Saliva. Lap Lambert Academic Publishing; Saarbrücken, Germany: 2011. [Google Scholar]
  5. Barral A, Honda E, Caldas A, Costa J, Vinhas V, Rowton ED, Valenzuela JG, Charlab R, Barral-Netto M, Ribeiro JM. Human immune response to sand fly salivary gland antigens: a useful epidemiological marker? Am J Trop Med Hyg. 2000;62:740–745. doi: 10.4269/ajtmh.2000.62.740. [DOI] [PubMed] [Google Scholar]
  6. Dubrovsky Y. Biology of great gerbil-the principal carrier of the great of Zoonotic Cutaneous Leishmaniasis. Ministry of Health; Moscow: 1979. WHO Traveling Seminar on Leishmaniasis Control. [Google Scholar]
  7. Gramiccia M, Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int J Parasitol. 2005;35:1169–1180. doi: 10.1016/j.ijpara.2005.07.001. [DOI] [PubMed] [Google Scholar]
  8. Hudson L, Hay FC. Practical Immunology. Blackwell Scientific Publications; London: 1991. [Google Scholar]
  9. Javadian E. Reservoir host of cutaneouse leishmaniasis in Iran. XII International Congress for Tropical Medicine and Malaria; 18–23 September 1988; Amsterdam, the Netherlands. 1988. p. 52. [Google Scholar]
  10. Javadian E, Dehestani M, Nadim A, Rassi Y, Tahvildare-Bidruni GH, Seyedi-Rashti MA, Shadmehr A. Confirmation of Tatera indica (Rodentia: Gerbillidae) as the main reservoir host of zoonotic cutaneous leishmaniasis in the west of Iran. Iranian J Publ Health. 1998;27:55–60. [Google Scholar]
  11. Kamhawi S. The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections. Microbes Infect. 2000;2:1765–1773. doi: 10.1016/s1286-4579(00)01331-9. [DOI] [PubMed] [Google Scholar]
  12. Kemp GD. Purification of Antibodies and Preparation of Antibody Fragments. In: Burns R, editor. Methods in Molecular Biology Vol 295: Immunochemical protocols. Humana Press Inc; Totowa, NJ: 2005. pp. 97–121. [DOI] [PubMed] [Google Scholar]
  13. Strelkova MV. Susceptibility to and the characteristics of the course of experimental leishmaniasis in different species of mammals infected with Leishmania major, L. turanica and L. gerbilli. Med Parizitol. 1991;1:35–39. [PubMed] [Google Scholar]
  14. Strelkova MV. Progress in studies on central asian foci of zoonotic cutaneous leishmaniasis a review. Folia Parasitol. 1996;43:1–6. [PubMed] [Google Scholar]
  15. Wilson B, Nakane PK. Recent developments in the periodate method of conjugating horseradish peroxidase (HRPO) to antibodies. In: Knapp W, Holubar K, Wick G, editors. Immunofluorescence and related staining techniques. Elsevier/North-Holland, Biomedical Press; Amsterdam: 1978. pp. 215–224. [Google Scholar]
  16. Yaghoobi-Ershadi MR, Javadian E. Epidemiological study of reservoir hosts in an endemic area of zoonotic cutaneous leishmaniasis in Iran. Bull WHO. 1996;74:587–590. [PMC free article] [PubMed] [Google Scholar]
  17. Yaghoobi-Ershadi MR, Akhavan AA, Mohebali M. Meriones libycus and Rhombomys opimus (Rodentia: Gerbillidae) are the main reservoir hosts in a new focus of zoonotic cutaneous leishmaniasis in Iran. Trans R Soc Trop Med Hyg. 1996;90:503–504. doi: 10.1016/s0035-9203(96)90295-3. [DOI] [PubMed] [Google Scholar]
  18. Yaghoobi-Ershadi MR, Akhavan AA, Zahraei-Ramazani AR, Abai MR, Ebrahimi B, Vafaei-Nezhad R, Hanafi-Bojd AA, Jafari R. Epidemiological study in a new focus of cutaneous leishmaniasis in the Islamic Republic of Iran. East Meditter Health J. 2003;9:816–826. [PubMed] [Google Scholar]
  19. Yaghoobi-Ershadi MR. Reservoir hosts of cutaneous leishmaniasis in Iran. In: Nadim A, Javadian E, Mohebali M, Zamen-Momeni A, editors. Leishmania. Parasite and Leishmaniasis, University Publishing Center; Tehran: 2008. pp. 177–190. [Google Scholar]

Articles from Iranian Journal of Arthropod-borne Diseases are provided here courtesy of Tehran University of Medical Sciences

RESOURCES